Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Paul P.-S. Wang"'
Autor:
Melissa K. Bennett, Manjun Li, Melinda N. Tea, Melissa R. Pitman, John Toubia, Paul P.-S. Wang, Dovile Anderson, Darren J. Creek, Robert Z. Orlowski, Briony L. Gliddon, Jason A. Powell, Craig T. Wallington-Beddoe, Stuart M. Pitson
Publikováno v:
Neoplasia: An International Journal for Oncology Research, Vol 24, Iss 1, Pp 1-11 (2022)
The introduction of the proteasome inhibitor bortezomib into treatment regimens for myeloma has led to substantial improvement in patient survival. However, whilst bortezomib elicits initial responses in many myeloma patients, this haematological mal
Externí odkaz:
https://doaj.org/article/f5e0bdd9d3004cfdbf70bbe296a47fe3
Autor:
Deepak, Singhal, Christopher N, Hahn, Simone, Feurstein, Li Yan A, Wee, Luke, Moma, Monika M, Kutyna, Rakchha, Chhetri, Leila, Eshraghi, Andreas W, Schreiber, Jinghua, Feng, Paul P-S, Wang, Milena, Babic, Wendy T, Parker, Song, Gao, Sarah, Moore, Soma, Das, David, Thomas, Swetansu, Pattnaik, Anna L, Brown, Richard J, D'Andrea, Nicola K, Poplawski, Daniel, Thomas, Hamish S, Scott, Lucy A, Godley, Devendra K, Hiwase
Publikováno v:
Leukemia. 35(11)
The majority of studies assessing the contribution of pathogenic germline variants (PGVs) to cancer predisposition have focused on patients with single cancers. We analyzed 45 known cancer predisposition genes (CPGs) in germline samples of 202 patien
Autor:
Deepak, Singhal, Li Yan A, Wee, Monika M, Kutyna, Rakchha, Chhetri, Joel, Geoghegan, Andreas W, Schreiber, Jinghua, Feng, Paul P-S, Wang, Milena, Babic, Wendy T, Parker, Smita, Hiwase, Suzanne, Edwards, Sarah, Moore, Susan, Branford, Teodora, Kuzmanovic, Nimit, Singhal, Raghu, Gowda, Anna L, Brown, Peer, Arts, Luen B, To, Peter G, Bardy, Ian D, Lewis, Richard J, D'Andrea, Jaroslaw P, Maciejewski, Hamish S, Scott, Christopher N, Hahn, Devendra K, Hiwase
Publikováno v:
Leukemia. 33(12)
Therapy-related myeloid neoplasms (T-MN) are poorly characterized secondary hematological malignancies following chemotherapy/radiotherapy exposure. We compared the clinical and mutational characteristics of T-MN (n = 129) and primary myelodysplastic